Accelerate Diagnostics slides 14% on stock offering

Becton Dickinson and Co

18/08/2022 12:50

** Accelerate Diagnostics' shares  AXDX.O  fall 14% to $2.9
before the bell
    ** AXDX announces late Thursday planned stock offering; Co
has not yet disclosed the offering size with William Blair and
Oppenheimer acting as bookrunners  urn:newsml:reuters.com:*:nPnbMbJ4Ma
    ** Says will use the net proceeds for general corporate
purposes and to fund commercialisation efforts 
    ** AXDX currently has 81.6 mln of shares outstanding and its
market value is $278.9 mln 
    ** AXDX is up 61% this week through Wednesday close after it
announced partnership with Becton Dickinson  BDX.N  on Monday
 urn:newsml:reuters.com:*:nL4N2ZR34S
    ** Stock still down ~34% YTD 

 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))